VA Spending on Hospital and Medical Care Exceeds $112 Billion Annually ENGLEWOOD, Colo. , Dec. 17, 2024 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced a new partnership to conduct business with... Read More

ENGLEWOOD, Colo. , Dec. 12, 2024 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced highlights from a recent study comparing its NiCO™ laser pulse oximeter to conventional LED pulse oximeters for the... Read More

ENGLEWOOD, Colo. , Dec. 5, 2024 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has completed its clinical verification trial for their NiCO™ pulse oximeter overseen by anesthesiologist Dr.... Read More

ENGLEWOOD, Colo. , Dec. 3, 2024 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced its membership in the Collaborative Community of the independently led Open Oximetry Project as an industry member. The... Read More

ENGLEWOOD, Colo. , Oct. 24, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the third quarter ended September 30, 2024 . Key Third Quarter Highlights and Business Update Q3 2024 orders increased... Read More

ENGLEWOOD, Colo. , Oct. 16, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, October 24, 2024 at 4:15 PM Eastern Time to discuss its financial results for the third quarter ended September 30 , 2024. Financial... Read More

ENGLEWOOD, Colo. , Sept. 4, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming HC Wainwright Global Investment Conference, which is being held September 9-11, 2024 . Zynex's fireside chat will be held in person... Read More

ENGLEWOOD, Colo. , Sept. 3, 2024 /PRNewswire/ -- Zynex Inc. (NASDAQ: ZYXI), a leading medical technology company specializing in non-invasive medical devices for pain management and rehabilitation, today announced FDA clearance of its new TensWave device. The TensWave device, by prescription only, builds on Zynex's strong legacy of innovation in pain management. It offers a user-friendly, portable design that can be easily... Read More

Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the second quarter ended June 30, 2024 . Key Second Quarter Highlights... Read More

ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, July 25, 2024 at 4:15 PM Eastern Time to discuss its financial results for the second quarter ended June 30 , 2024. Financial results... Read More

ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has been recognized for multiple awards by Top Workplaces and the U.S. News & World Report 2024-2025 ratings. Top Workplaces, the nation's most credible... Read More

ENGLEWOOD, Colo. , June 10, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it will participate in an analyst-led fireside chat on an RBC Capital Markets 2024 Medical Device Strategy & Innovation Call at 11:00 AM ET on Thursday,... Read More

ENGLEWOOD, Colo. , May 9, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming RBC Capital Markets Global Healthcare Conference, which is being held May 14-15, 2024 . Zynex's presentation will be held in person and... Read More

ENGLEWOOD, Colo. , May 7, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today is proud to announce that two of our executives have been featured among Medical Technology's Top 25 by The Healthcare Technology Report . This prestigious recognition... Read More

Q1 2024 Revenue Increased 10% to $46.5 Million ENGLEWOOD, Colo. , April 30, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the first quarter ended March 31, 2024 . Key First Quarter Highlights... Read More

ENGLEWOOD, Colo. , April 18, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, April 30, 2024 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31 , 2024. Financial results... Read More

ENGLEWOOD, Colo. , April 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it is a recipient of the prestigious 2024 Top Workplaces USA award, featured in USA TODAY. This achievement underscores the organization's dedication to... Read More

FY 2023 Revenue Increased 17% to $184.3 Million Company Announces Additional $20 Million Stock Repurchase Plan ENGLEWOOD, Colo. , Feb. 29, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the... Read More

ENGLEWOOD, Colo. , Feb. 22, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, February 29, 2024 at 4:15 PM Eastern Time to discuss its financial results for the fourth quarter and full year ended December 31, 2023... Read More

ENGLEWOOD, Colo. , Feb. 20, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, introduced two new therapy products: the Zynex Pro Hybrid LSO and the Zynex DynaComp Cold Compression. The Zynex Pro Hybrid LSO is a versatile 3-in-1 spinal orthosis featuring... Read More

ENGLEWOOD, Colo. , Feb. 6, 2024 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has received clearance from the U.S. Food and Drug Administration ("FDA") for the next generation M-Wave Neuromuscular Electrical Stimulation ("NMES")... Read More

ENGLEWOOD, Colo. , Feb. 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced The Healthcare Technology Report recognized Zynex as 9 th amongst the Top 25 Medical Device Companies for 2024 . "We're pleased to be included in the Top 25... Read More

ENGLEWOOD, Colo. , Jan. 8, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will participate virtually in the upcoming Needham Annual Growth Conference, which is being held January 16 th -19 th , 2024. Dan Moorhead , CFO, will be available... Read More

ENGLEWOOD, Colo. , Nov. 15, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked within Forbes' list of America's Most Successful Small-Cap Companies for 2024. The 2024 Forbes list of America's Most Successful... Read More

ENGLEWOOD, Colo. , Nov. 13, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical Stimulation ("NMES")... Read More

ENGLEWOOD, Colo. , Nov. 9, 2023 /PRNewswire/ -- Zynex, Inc. ( NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked among all companies in the U.S. and Canada between 2019 and 2022 on Deloitte's Technology Fast 500. Zynex's revenues grew 248% over... Read More

ENGLEWOOD, Colo. , Nov. 1, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to repurchase up to $20.0 million of the Company's common stock. The program will commence on November 1, 2023 ,... Read More

ENGLEWOOD, Colo. , Oct. 31, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring , today announced its Board of Directors (the "Board") has initiated a process to evaluate potential strategic alternatives to maximize shareholder value. As part of the... Read More

Q3 2023 Revenue Increased 20% to $49.9 Million ; EPS $0.10 ENGLEWOOD, Colo. , Oct. 26, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has reported its financial and operational results for the third quarter ended September 30, 2023 . Key Third Quarter... Read More

ENGLEWOOD, Colo. , Oct. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced The Healthcare Technology Report has recognized Zynex as 23 rd in the Top 100 Healthcare Technology Companies of 2023 . 2023 is the second year Zynex has been... Read More

ENGLEWOOD, Colo. , Oct. 12, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, October 26, 2023 at 4:15 PM Eastern Time to discuss its financial results for the third quarter ended September 30 , 2023. Financial... Read More

ENGLEWOOD, Colo. , Sept. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming Cantor Global Healthcare Conference, which is being held September 26 th -28 th , 2023. Zynex's presentation will be held in person... Read More

ENGLEWOOD, Colo. , Sept. 11, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to repurchase $10.0 million of the Company's common stock. The program will commence on September 13, 2023 ,... Read More

ENGLEWOOD, Colo. , Sept. 5, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming H.C. Wainwright Global Investment Conference, which is being held on September 11 th -13 th , 2023. Zynex's presentation will be held... Read More

ENGLEWOOD, Colo. , Aug. 10, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced that, since its founding, the company has treated more than 1 million patients through its pain management division. Zynex manufactures and sells the NexWave... Read More

ENGLEWOOD, Colo. , Aug. 9, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced the addition of three new therapy products centered around pain management. The new products include Zynex Pro Thoracic Lumbar Sacral Orthosis ("TLSO"), a dual-purpose... Read More

ENGLEWOOD, Colo. , Aug. 3, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has the company's Founder and CEO, Thomas Sandgaard will participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar at 12:15 PM ET on August 3 rd , 2023.... Read More

Q2 2023 Revenue increased 22% to $45.0 Million ; EPS $0.09 ENGLEWOOD, Colo. , July 27, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has reported its financial and operational results for the second quarter ended June 30, 2023 . Key Second Quarter... Read More

ENGLEWOOD, Colo. , July 20, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, July 27, 2023 at 4:15 PM Eastern Time to discuss its financial results for the second quarter, 2023 ended June 30, 2023 . Financial... Read More

ENGLEWOOD, Colo. , July 17, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has won the Top Workplace Award among manufacturers, given by Energage, LLC, an employee engagement technology partner. Winners are chosen based on an anonymous third-party... Read More

ENGLEWOOD, Colo. , July 12, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for second quarter 2023 and reiterated full-year guidance. "Zynex continues to see strong growth in our pain management division across... Read More

ENGLEWOOD, Colo. , July 10, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has engaged international investor relations specialists MZ Group ("MZ") to lead their comprehensive strategic investor relations and financial communications program across... Read More

ENGLEWOOD, Colo. , June 20, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the FDA (Food and Drug Administration) has granted 510(k) market clearance for the company's CM-1600 blood and fluid volume monitoring device. "I am... Read More

ENGLEWOOD, Colo. , June 14, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to buy back $10.0 million of the Company's common stock. The program will commence on June 14, 2023 and is... Read More

ENGLEWOOD, Colo. , May 4, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), announced today the pricing of its previously announced private offering of $52.5 million aggregate principal amount of 5.00% convertible senior notes due 2026 (the "Notes") in a private offering (the "Notes Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933,... Read More

ENGLEWOOD, Colo. , May 4, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced that Thomas Sandgaard , its Chief Executive Officer (the "Selling Stockholder"), has determined not to pursue the public offering of 2,000,000 shares of the Company's common stock that was previously announced on May 3, 2023 (the "Secondary Offering"). The decision results from an assessment by the Selling Stockholder that... Read More

ENGLEWOOD, Colo. , May 3, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex" or "the Company") (Nasdaq: ZYXI), today announced the commencement of an underwritten public offering of 2,000,000 shares of its common stock by Thomas Sandgaard , its Chief Executive Officer (the "Secondary Offering"). Mr. Sandgaard also intends to grant the underwriter a 30-day option to purchase up to an additional 300,000 shares of the Company's common... Read More

ENGLEWOOD, Colo. , May 3, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced its intent to offer, subject to market conditions and other factors, $50 million aggregate principal amount of its convertible senior notes due 2026 (the "Notes") in a private offering (the "Notes Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of... Read More

ENGLEWOOD, Colo. , May 3, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has been named by The Denver Post as a winner of... Read More

ENGLEWOOD, Colo. , April 27, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the first quarter ended March 31, 2023 . First Quarter 2023 Highlights: Revenue increased 36% year-over-year to $42.2 million Net income... Read More

ENGLEWOOD, Colo. , April 19, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report first quarter 2023 financial results on Thursday, April 27, 2023 . Zynex's management will host a conference call and webcast at... Read More

ENGLEWOOD, Colo. , April 11, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for first quarter 2023 and reiterated full year guidance. "We continue to execute in both our divisions, and in our pain management... Read More

ENGLEWOOD, Colo. , April 6, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has been ranked 191 out of 500 on The Financial Times fourth annual list of The Americas' Fastest Growing Companies 2023. "Zynex has consistently grown... Read More

ENGLEWOOD, Colo. , March 21, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Denver Business Journal has ranked Zynex sixth in a list of the largest Denver -area Biotechnology/Bioscience companies, according to the number of... Read More

ENGLEWOOD, Colo. , March 13, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2022 . 2022 Fourth Quarter Highlights Orders increased 48%; highest number of orders... Read More

ENGLEWOOD, Colo. , March 10, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report fourth quarter and full-year 2022 financial results on Monday, March 13, 2023 . Zynex's management will host a conference call... Read More

ENGLEWOOD, Colo. , March 6, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will postpone the release of its fourth quarter and full year financial results and conference call initially scheduled for Monday, March 6,... Read More

ENGLEWOOD, Colo. , Feb. 23, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report fourth quarter and full-year 2022 financial results on Monday, March 6, 2023 . Zynex's management will host a conference call and... Read More

ENGLEWOOD, Colo. , Feb. 21, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the lease of a new 41,000 square foot facility to accommodate Zynex Monitoring Solution's (ZMS) current and expected future growth. "The considerable expansion... Read More

ENGLEWOOD, Colo. , Feb. 17, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it is set to join the MSCI USA Small Cap Index according to the list of additions posted by MSCI on February 9, 2023 . Inclusion in the index will take... Read More

ENGLEWOOD, Colo. , Feb. 1, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, today reported it will be hosting a blood donation drive on February 1, 2023 at its headquarters in Englewood, CO in partnership with Vitalant, the nation's largest independent,... Read More

ENGLEWOOD, Colo. , Jan. 31, 2023 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced The Healthcare Technology Report has recognized Zynex in The Power 500 Healthcare Technology Companies. "We are honored to be included in The Power 500... Read More

ENGLEWOOD, Colo. , Jan. 17, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for fourth quarter 2022 and reiterated full year guidance. "We experienced yet another quarter of record order growth in the fourth quarter... Read More

ENGLEWOOD, Colo. , Dec. 22, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has been ranked 11 th on Forbes list of America's Best Small Companies for 2023. The 2023 Forbes list of America's Best Small Companies can be found at... Read More